Skip to main content
Premium Trial:

Request an Annual Quote

IP Update: Recent Patents Awarded to MIT, Applied Biosystems, and More

Premium

Title: System for Targeted Delivery of Therapeutic Agents

Patent Number: 8,709,483

Filed: Sept. 26, 2008

Lead Inventor: Omid Farokhzad, Massachusetts Institute of Technology


Title: Treatment of Influenza

Patent Number: 8,710,024

Filed: May 11, 2012

Lead Inventor: Misako Nakazawa, Kyorin Pharmaceutical


Title: miR-204, miR-211, and Their Anti-miRs, and Therapeutic Uses of the Same

Patent Number: 8,710,026

Filed: May 16, 2013

Lead Inventor: Sheldon Miller, US Department of Health and Human Services


Title: Method to Quantify siRNAs, miRNAs, and Polymorphic miRNAs

Patent Number: 8,710,208

Filed: April 26, 2012

Lead Inventor: Ruoying Tan, Applied Biosystems

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.